Ehinger M - Search Results

1

Transplantation of Haploidentical TcRaß-Depleted Hematopoietic Cells Allows for Optimal Timing and Sustained Correction of the Metabolic Defect in Children With Infantile Osteopetrosis.

Pronk CJ, Turkiewicz D, Vult von Steyern K, Ehinger M, Dykes J, Toporski J. Pronk CJ, et al. Among authors: ehinger m. J Bone Miner Res. 2017 Jan;32(1):82-85. doi: 10.1002/jbmr.2921. Epub 2016 Sep 8. J Bone Miner Res. 2017. PMID: 27447118 Free article.

2

Neonatal hematopoietic stem cell transplantation cures oc/oc mice from osteopetrosis.

Johansson M, Jansson L, Ehinger M, Fasth A, Karlsson S, Richter J. Johansson M, et al. Among authors: ehinger m. Exp Hematol. 2006 Feb;34(2):242-9. doi: 10.1016/j.exphem.2005.11.010. Exp Hematol. 2006. PMID: 16459192 Free article.

3

Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice.

Johansson MK, de Vries TJ, Schoenmaker T, Ehinger M, Brun AC, Fasth A, Karlsson S, Everts V, Richter J. Johansson MK, et al. Among authors: ehinger m. Blood. 2007 Jun 15;109(12):5178-85. doi: 10.1182/blood-2006-12-061382. Epub 2007 Mar 1. Blood. 2007. PMID: 17332244 Free article.

4

Nonablative neonatal bone marrow transplantation rapidly reverses severe murine osteopetrosis despite low-level engraftment and lack of selective expansion of the osteoclastic lineage.

Flores C, de Vries TJ, Moscatelli I, Askmyr M, Schoenmaker T, Langenbach GE, Ehinger M, Everts V, Richter J. Flores C, et al. Among authors: ehinger m. J Bone Miner Res. 2010 Sep;25(9):2069-77. doi: 10.1002/jbmr.90. J Bone Miner Res. 2010. PMID: 20568230 Free article.

5

Immunologic Control of Disseminated Aichi Virus Infection in X-Linked Agammaglobulinemia by Transplantation of TcRαβ-Depleted Haploidentical Hematopoietic Cells.

Bekassy Z, Ehinger M, Pronk LN, Pronk CJ; SMPOT group. Bekassy Z, et al. Among authors: ehinger m. J Clin Immunol. 2022 Oct;42(7):1401-1404. doi: 10.1007/s10875-022-01314-5. Epub 2022 Jul 5. J Clin Immunol. 2022. PMID: 35788939 Free PMC article. No abstract available.

6

Successful low-risk hematopoietic cell therapy in a mouse model of type 1 Gaucher disease.

Enquist IB, Nilsson E, Månsson JE, Ehinger M, Richter J, Karlsson S. Enquist IB, et al. Among authors: ehinger m. Stem Cells. 2009 Mar;27(3):744-52. doi: 10.1634/stemcells.2008-0844. Stem Cells. 2009. PMID: 19056909

7

Low-dose busulphan conditioning and neonatal stem cell transplantation preserves vision and restores hematopoiesis in severe murine osteopetrosis.

Askmyr M, Holmberg J, Flores C, Ehinger M, Hjalt T, Richter J. Askmyr M, et al. Among authors: ehinger m. Exp Hematol. 2009 Feb;37(2):302-8. doi: 10.1016/j.exphem.2008.10.010. Epub 2008 Dec 18. Exp Hematol. 2009. PMID: 19100677 Free article.

8

SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.

Hansen N, Ågerstam H, Wahlestedt M, Landberg N, Askmyr M, Ehinger M, Rissler M, Lilljebjörn H, Johnels P, Ishiko J, Melo JV, Alexander WS, Bryder D, Järås M, Fioretos T. Hansen N, et al. Among authors: ehinger m. Leukemia. 2013 Jan;27(1):130-5. doi: 10.1038/leu.2012.169. Epub 2012 Jun 22. Leukemia. 2013. PMID: 22824785 Free PMC article.

9

Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.

Kolstad A, Pedersen LB, Eskelund CW, Husby S, Grønbæk K, Jerkeman M, Laurell A, Räty R, Elonen E, Andersen NS, Brown PD, Kimby E, Bentzen H, Sundström C, Ehinger M, Karjalainen-Lindsberg ML, Delabie J, Ralfkiær E, Fagerli UM, Nilsson-Ehle H, Lauritzsen GF, Kuittinen O, Niemann C, Geisler CH; Nordic Lymphoma Group. Kolstad A, et al. Among authors: ehinger m. Biol Blood Marrow Transplant. 2017 Mar;23(3):428-435. doi: 10.1016/j.bbmt.2016.12.634. Epub 2016 Dec 27. Biol Blood Marrow Transplant. 2017. PMID: 28039078 Free article. Clinical Trial.

10

Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML.

Delsing Malmberg E, Johansson Alm S, Nicklasson M, Lazarevic V, Ståhlman S, Samuelsson T, Lenhoff S, Asp J, Ehinger M, Palmqvist L, Brune M, Fogelstrand L. Delsing Malmberg E, et al. Among authors: ehinger m. Leuk Lymphoma. 2019 Feb;60(2):409-417. doi: 10.1080/10428194.2018.1485910. Epub 2018 Aug 2. Leuk Lymphoma. 2019. PMID: 30068244 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters